The Progressive Corporation
PGR - NYSE - $199.31 ▼ -%0.98
-
Earnings Wed 15 Jul

Progressive opens the
books on Wednesday evening.

11 analysts' median target is $225[FMP target], stock is $199, +12.9% upside potential. After Q4 +2.3% EPS beat[FMP earnings], the stock moved +1.1%.

summary below
Quick Take - in 40 seconds
B+
HOLD Council 2/6 - Moonshot 37

B+ = MoonshotScore 37[9-pillar formula] + Council 2/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q4 consensus: revenue $21.7B[FMP est], EPS $3.82[FMP est]. 2 consecutive quarters of beat[FMP earnings].

$3.82 EPS Estimate Last year $4.67 - -22% YoY YoY
2 Beat Streak Expectations beaten consecutively for the last 2 quarters

Q4 EPS +2.3% beat[FMP] but the stock +1.1% D+1[FMP D+1]. John Sauerland promised $121.0M CapEx + a sequential decline in Q4 during the Q4 earnings call[John Sauerland capex transcript].

Watchlist

5 metrics stand out this quarter.

12% Investor Focus

Policy Growth

policy_growth

Progressive's policies in force grew by 12%, led by personal vehicles with almost 3.5 million more policies, equating to almost 5.5 million more vehicles insured by Progressive.

"Profitability across our businesses was excellent, and policy in force growth was also positive across all the businesses with personal vehicles leading at 12% or almost 3.5 million more policies than last year. That equates to almost 5.5 million more vehicles insured by Progressive versus year-end 2024."

- John Sauerland, CFO - Q4 FY25 Earnings Call - March 3, 2026
2 Investor Focus

Market Share Growth

market_share_growth

Progressive gained approximately 2 points of market share in the private passenger auto market through Q3 2025, reaching around 18.5% market share.

"When we look at statutory results for the private passenger auto market through the third quarter of 2025, we believe we picked up close to an additional 2 points of market share versus last year to move to around 18.5% market share."

- John Sauerland, CFO - Q4 FY25 Earnings Call - March 3, 2026
$13.50 Investor Focus

Variable Dividend

variable_dividend

Progressive rewarded its shareholders with a $13.50 per share variable dividend in January, largely reflecting robust capital generation in 2025.

"The combination of the strong capital position in which we entered 2025, robust income generation and increased operating leverage allowed for Progressive to reward our shareholders with a $13.50 per share variable dividend in January."

- John Sauerland, CFO - Q4 FY25 Earnings Call - March 3, 2026
3.5:1 Investor Focus

Operating Leverage Increase

operating_leverage_increase

Progressive has received approval to move its operating leverage up to a maximum of 3.5:1 premiums to surplus at its insurance companies, potentially increasing return on equity.

"As we conveyed in our Form 10-Q for the third quarter of 2025, we have received approval from our regulators that oversee most of our operating entities to move our operating leverage up to a maximum of 3.5:1 premiums to surplus."

- John Sauerland, CFO - Q4 FY25 Earnings Call - March 3, 2026
$13 billion Investor Focus

Comprehensive Income

comprehensive_income

Progressive earned almost $13 billion in comprehensive income across its operating and investing units in 2025, equating to a comprehensive return on equity of 40%.

"We earned almost $13 billion in comprehensive income across our operating and investing units or a comprehensive return on equity of 40%."

- John Sauerland, CFO - Q4 FY25 Earnings Call - March 3, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 2 / 6 Bullish

6 investor frameworks. 2 bullish (Ray Dalio, Buffett), 1 bearish (Ken Griffin), 3 neutral (Jim Simons, Klarman, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +12.9%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 46
Klarman value - target upside +12.9%
Buffett quality - ROE score 5/5
Munger valuation - target upside +12.9%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
46.1 RSI 46.1 balanced, 50d below
MACD
-2.00 price below 50d - resistance dominant
50d MA
$203 stock 2.0% below - short-term resistance
200d MA
$222 stock 10.3% below - long-term pressure
Volume (10d)
-23% decrease - low participation
Resistance
$225
Analyst median target - upgrade trigger if broken
Current
$199
Pre-earnings position
Support
$189
Invalidation - close below this is a technical breakdown
Pattern
Range
$189-$225 band - earnings breakout/breakdown trigger

Past Performance

The's last 8 quarters: 2 consecutive beats.

BEAT
Q2 FY25
$4.88 vs $4.48 est - +0.3%
MISS
Q3 FY25
$4.05 vs $4.99 est - -2.1%
BEAT
Q4 FY25
$4.67 vs $4.44 est - -2.1%
BEAT
Q1 FY26
$4.96 vs $4.85 est - +1.1%

Q4 (March 3, 2026): EPS $4.96 vs $4.85 est[FMP], +2.3% beat. D+1 movement: +1.1%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $3.71 (no guidance)

Q4: EPS $4.96 vs $4.85 beat[FMP], stock +1.1% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q4 earnings call.

CapEx shock

Q4 CapEx $121.0M[FMP cashflow]. Q4 op margin 16.1%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q4 EPS > $3.82 + CapEx discipline
Threshold: EPS > $3.82[FMP est].
Target: Break above median target $225[FMP target]; high target $259[FMP] upper bound.
Scenario B - In-Line
EPS approx $3.82 + CapEx < $121.0M
Threshold: EPS approx $3.82[FMP est], Q4 CapEx < $121.0M[FMP].
Target: Consolidation in the band between current $199[FMP] and median $225[FMP].
Scenario C - Miss
EPS < $3.71 or CapEx >= $121.0M
Threshold: EPS < $3.71[FMP estx0.97].
Target: Current $199 below SMA200 $222[FMP], if rejection continues, $189[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 11 analysts say?

Wall Street Consensus
$225
12-month median target price (+12.9% upside potential)
7
BUY
16
HOLD
1
SELL
Risk Management
$189
Invalidation level - critical support threshold
$203 - 50-day MA (below, -2.0%)
$222 - 200-day MA (below, -10.3%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - PGR Q4 FY26
B+

You read it in 5 minutes. When the numbers come out on Wednesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Wednesday evening. The framework is ready on this page: Q4 EPS threshold $3.82[FMP], CapEx threshold "below $121.0M"[John Sauerland]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Jul 15, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
Jul 16, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Aug 29, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Oct 15, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the PGR earnings preview cover?

This PGR (PGR) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in PGR earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.